NS1-binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c-Myc

BACKGROUND: Cisplatin-based chemotherapy with concurrent radiotherapy is a standard treatment for advanced esophageal squamous cell carcinoma (ESCC). NS1-binding protein (NS1-BP), a member of the BTB-kelch protein family, has been shown to inhibit the proliferation of Hela cells by suppressing c-Myc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuwen, Cheng, Jingjing, Xie, Dan, Ding, Xiaofeng, Hou, Hailing, Chen, Xi, Er, Puchun, Zhang, Furong, Zhao, Lujun, Yuan, Zhiyong, Pang, Qingsong, Wang, Ping, Qian, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993120/
https://www.ncbi.nlm.nih.gov/pubmed/29871674
http://dx.doi.org/10.1186/s40880-018-0307-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993120/
https://www.ncbi.nlm.nih.gov/pubmed/29871674
http://dx.doi.org/10.1186/s40880-018-0307-y

Ejemplares similares